Regular ecstasy (MDMA) use can cause lasting changes to your brain’s serotonin system, measurable memory problems, increased risk of depression, disrupted sleep, dental damage, and possible heart valve changes. The severity depends heavily on how much you’ve used and for how long. Brain imaging studies show serotonin transporter reductions of 17% to 46% across different brain regions in heavy users, though there’s encouraging evidence that much of this damage can reverse after a year or more of abstinence.
How Ecstasy Changes Your Serotonin System
MDMA works by flooding the brain with serotonin, the chemical messenger that regulates mood, sleep, appetite, and body temperature. With repeated use, this takes a toll on the system responsible for recycling serotonin. Brain imaging studies using PET scans have found that heavy ecstasy users show significant reductions in serotonin transporter density across the entire outer layer of the brain and in the hippocampus, a region critical for memory. The most dramatic drops appeared in the visual processing area at the back of the brain (a 39% to 46% reduction) and in the temporal and cingulate regions (around 30% to 34%).
These reductions correlate with years of use and maximum doses taken. Importantly, the same imaging studies found no significant differences in overall brain volume, white matter, or ventricle size between heavy users and non-users. So ecstasy doesn’t appear to shrink the brain structurally, but it does alter its chemistry in ways that affect day-to-day function. One exception: users who also took methamphetamine showed slight cortical thinning on the left side of the brain.
Memory and Thinking Problems
The most consistently documented cognitive effect of long-term ecstasy use is impaired verbal memory. Studies find that heavy users struggle with both immediate and delayed word recall, paragraph recall, and learning new sequences of information. In one study, people who had taken an average of roughly 130 tablets showed measurable impairment in recalling stories both right after hearing them and after a delay. Heavier users (averaging around 584 tablets over a lifetime) also showed deficits in sustained attention, logical reasoning, and working memory.
These aren’t dramatic losses that make daily life impossible for most people. Researchers describe them as “subtle” but real, and they show up on standardized cognitive tests even when the effects of other drugs like cannabis are accounted for. Face recognition, spatial learning, and the ability to plan ahead can also be affected. The deficits tend to scale with total lifetime consumption: the more ecstasy someone has taken, the worse the memory and executive function scores.
Critically, these cognitive problems can persist. Deficits in verbal recall and working memory have been documented at least six months and up to an average of two years after someone stops using entirely.
Depression and Mood Disorders
Former ecstasy users carry a notably higher burden of mood disorders than the general population. Data from the National Epidemiologic Survey on Alcohol and Related Conditions found that 42.1% of former ecstasy users met criteria for a lifetime mood disorder, and 27.8% had a current mood disorder at the time of the survey. Former users were 3.5 times more likely to have a current mood disorder and 2.6 times more likely to have current major depression compared to people who had never used illicit drugs.
An interesting pattern emerged in that data: current ecstasy users didn’t show the same elevated depression rates. It was specifically former users, people who had stopped, who had the highest prevalence of major depression. This may reflect the long-term toll of serotonin depletion catching up once the acute mood-boosting effects of the drug are no longer in the picture. It could also reflect the possibility that some people stop using ecstasy because they’ve already started experiencing mood problems, but the biological plausibility of serotonin damage driving depression is strong.
Sleep Disruption
Ecstasy users commonly report poor sleep quality that persists well beyond the nights they use. In one study, abstinent MDMA users were 15 times more likely to report clinically poor sleep compared to non-users. The odds of reporting low sleep quality specifically were nearly tenfold higher. This wasn’t just subjective complaining: when researchers deprived both groups of sleep, the ecstasy users showed steeper declines in cognitive performance, including more impulsive responses and less accurate reasoning. The researchers found that the users’ pre-existing sleep disturbance was what drove those steeper declines, suggesting that damaged serotonin function makes the brain less resilient to everyday stressors like a bad night’s sleep.
Heart Valve Damage
A less well-known risk involves the heart. MDMA activates a specific serotonin receptor on heart valves, the same receptor targeted by the weight-loss drugs fenfluramine and dexfenfluramine, which were pulled from the market in the late 1990s for causing heart valve disease. In one study of 29 ecstasy users, eight had abnormal mitral valve findings on echocardiography compared to zero in the control group. The valve lesions looked very similar to those caused by the banned appetite suppressants. This risk is still considered underresearched, but the biological mechanism is well established, and it may be especially relevant for people who have used heavily over many years.
Dental and Jaw Damage
Jaw clenching and teeth grinding (bruxism) are almost universal during MDMA use. In experimental studies, roughly 75% to 89% of users report clenching their teeth, and the grinding can continue for up to 48 hours after a dose. Over time, this causes real structural damage. One study found that tooth wear extending through the enamel into deeper layers occurred in 60% of ecstasy users, compared to just 11% of non-users. The damage concentrates on the molars, where grinding forces are highest.
Beyond tooth wear, about half of regular users develop a habit of grinding even outside of drug use, and more than half report jaw pain, tenderness, or clicking in the jaw joint. MDMA also dries out the mouth, which accelerates tooth decay and erosion by removing saliva’s protective buffering.
Liver Toxicity
Acute liver damage from ecstasy is a recognized emergency room presentation, but chronic liver injury from prolonged use is less commonly discussed. Case reports document severe liver fibrosis, a buildup of scar tissue, in people using ecstasy regularly over months. One documented case involved a 27-year-old woman who developed serious liver failure with scarring and fluid buildup after nine months of ecstasy and cocaine use. The encouraging finding was that liver fibrosis progressively reversed after she stopped using both drugs. Still, prolonged use, particularly combined with cocaine or other substances, can push the liver toward damage that mimics chronic hepatitis.
Can the Brain Recover?
The most reassuring finding in the research is that serotonin transporter levels appear to normalize after sustained abstinence. Multiple imaging studies have found that former ecstasy users who stopped for more than a year showed serotonin transporter binding indistinguishable from people who had never used the drug. Follow-up studies confirmed a significant increase in transporter binding over time in both current users who reduced their intake and former users who quit entirely.
This doesn’t mean all effects reverse completely. Memory deficits and mood changes can linger for at least a couple of years after stopping, and whether the heaviest users ever fully recover their cognitive baseline is unclear. But the serotonin system itself shows a meaningful capacity for repair when given enough time without further exposure.
What You’re Actually Taking
One complicating factor in understanding ecstasy’s long-term effects is that street ecstasy often isn’t pure MDMA. An analysis of alleged MDMA samples in the United States spanning 25 years identified 199 unique adulterants. The most common contaminants have been caffeine and synthetic piperazines (chemicals once marketed as legal MDMA alternatives), and the specific adulterants shift over time, reflecting an unstable and unpredictable market. The increasing presence of fentanyl in illicit drug supplies adds an additional layer of risk that has nothing to do with MDMA itself. Any long-term user is likely accumulating exposure not just to MDMA but to an unknown mix of other substances, each carrying its own health consequences.